Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund Post author:Sam Post published:July 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Prometic Snags Rare Pediatric Disease Designation from the FDA for its Inter-Alpha-Inhibitor-Prot… March 4, 2018 Study Reveals Huge Potential for mRNA Drug Targets March 18, 2018 Ophthotech's Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study August 13, 2017
Prometic Snags Rare Pediatric Disease Designation from the FDA for its Inter-Alpha-Inhibitor-Prot… March 4, 2018